Researchers from Tufts University School of Dental Medicine have developed lab-grown skin that replicates the complexity of scleroderma. Made from patient-derived cells, the 3D tissue model increases understanding of how this and fibrotic diseases progress.

A promising breakthrough in cancer treatment is taking shape at the University of Missouri Research Reactor (MURR), where scientists are developing a powerful radioisotope that could one day precisely target and destroy cancer cells. A recent study led by Heather Hennkens, an associate professor at Mizzou’s Department of Chemistry and a researcher at MURR, investigated how to produce, purify and formulate Terbium-161 for radiopharmaceutical use. Through this work, Hennkens’ lab is optimizing the radioisotope so it can be effectively attached to a targeting molecule and sent as the therapeutic “payload” to destroy tumor cells.